Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

An exemplar outcome of an immunology-based intervention is vaccine development; the current COVID-19 pandemic is a case in point. Can we build an immunology research ecosystem in Africa that nurtures discovery and enables translation? We see African immunologists as key agents of change and discuss obstacles and opportunities.

Original publication

DOI

10.1016/j.it.2020.10.007

Type

Journal

Trends in immunology

Publication Date

12/2020

Volume

41

Pages

1051 - 1053

Addresses

Centre of Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany; KEMRI Wellcome Trust Research Programme, Centre for Geographic Medicine Research-Coast, Kilifi, Kenya. Electronic address: FOsier@kemri-wellcome.org.

Keywords

Humans, Allergy and Immunology, Developing Countries, Africa, SARS-CoV-2, COVID-19 Vaccines